1-9 of 9
Stefanie Schauer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinicohematologic and Molecular Response of Essential Thrombocythemia Patients Treated with Pegylated Interferon-Alpha: A Multicenter Study on Behalf of the German Study Group-MPN (GSG-MPN)

Frank Stegelmann, Lino L. Teichmann, Florian H. Heidel, Carl C. Crodel, Thomas Ernst, Sebastian Kreil, Andreas Reiter, Sara Otten, Stefanie Schauer, Ruth-Miriam Körber, Kim Kricheldorf, Susanne Isfort, Hartmut Döhner, Tim H. Brümmendorf, Martin Griesshammer, Konstanze Döhner, Steffen Koschmieder
Journal: Blood
Blood (2022) 140 (Supplement 1): 6874–6876.
https://doi.org/10.1182/blood-2022-165034
Published: 2022
Journal Articles

Long-Term Interferon-α Treatment in Essential Thrombocythemia

Frank Stegelmann, MD, Stefanie Schauer, Rebecca Kirschbaum, Hartmut Döhner, Prof. Dr., Richard F. Schlenk, MD, Martin Griesshammer, MD, Konstanze Döhner, MD
Journal: Blood
Blood (2015) 126 (23): 4064.
https://doi.org/10.1182/blood.V126.23.4064.4064
Published: 2015
Journal Articles

A Multicenter Phase-Ib/II Study of Ruxolitinib/Pomalidomide Combination Therapy in Patients with Primary and Secondary Myelofibrosis: Safety Data from the Mpnsg-0212 Trial (NCT01644110)

Frank Stegelmann, MD, Martin Griesshammer, Andreas Reiter, MD, Andreas Hochhaus, MD, Florian H Heidel, MD, Cora Heiligensetzer, Ulrike Sutter, Regina Reim, Stefanie Schauer, Rebecca Kirschbaum, Hartmut Döhner, MD, Richard F. Schlenk, MD, Konstanze Döhner, MD
Journal: Blood
Blood (2014) 124 (21): 3161.
https://doi.org/10.1182/blood.V124.21.3161.3161
Published: 2014
Journal Articles

Pomalidomide in Myelofibrosis with Cytopenia: First Results of the Mpnsg 01–09 Study (ClinicalTrials.gov Identifier: NCT00949364).

Richard F Schlenk, MD, Andreas Reiter, MD, Norbert Gattermann, MD, Holger Hebart, Edgar Jost, MD, Uwe Platzbecker, MD, Andreas Hochhaus, MD, Cornelius F. Waller, MD, Philippe Schafhausen, Igor W. Blau, MD, Walter Verbeek, MD, Martin Werner, MD, Hans H. Kreipe, MD, Carolin Mahler, Silja Mack, MSc, Stefanie Schauer, Sabine Ostlender, Frank Stegelmann, MD, Axel Benner, Dipl.Stat., Martin Griesshammer, MD, Konstanze Döhner, MD
Journal: Blood
Blood (2012) 120 (21): 2840.
https://doi.org/10.1182/blood.V120.21.2840.2840
Published: 2012
Journal Articles

Mutations of EZH2 In Myeloproliferative Neoplasms with Myelofibrosis: Correlation with Molecular and Clinical Data

Frank Stegelmann, MD, Richard F. Schlenk, MD, Martin Griesshammer, MD, Peter Paschka, Carmen Blersch, Susanne Kuhn, Stefanie Schauer, Hartmut Döhner, MD, Konstanze Döhner, MD
Journal: Blood
Blood (2010) 116 (21): 4111.
https://doi.org/10.1182/blood.V116.21.4111.4111
Published: 2010
Journal Articles

SNP-Array Profiling Identifies Complex Aberrations and Candidate Genes in Myeloproliferative Neoplasms with Leukemic Transformation.

Frank Stegelmann, Martin Griesshammer, Karlheinz Holzmann, Frank G Rücker, Carmen Blersch, Susanne Kuhn, Stefanie Schauer, Hartmut Dohner, Konstanze Dohner
Journal: Blood
Blood (2009) 114 (22): 2608.
https://doi.org/10.1182/blood.V114.22.2608.2608
Published: 2009
Journal Articles

High-Resolution SNP-Array Profiling Discloses Novel Genomic Aberrations in BCR/ABL-Negative Myeloproliferative Neoplasms with Myelofibrosis

Frank Stegelmann, Lars Bullinger, Martin Griesshammer, Susanne Kuhn, Stefanie Schauer, Katja Urlbauer, Simone Miller, Karlheinz Holzmann, Hartmut Dohner, Konstanze Dohner
Journal: Blood
Blood (2008) 112 (11): 2794.
https://doi.org/10.1182/blood.V112.11.2794.2794
Published: 2008
Journal Articles

Pregnancies in Patients with Philadelphia Negative Chronic Myeloproliferative Disorders: Interim Report of the European LeukemiaNet Data Base

Sabine Struve, Guido Finazzi, Konstanze Doehner, Stefanie Schauer, Eva Lengfelder, Heinz Gisslinger, Tiziano Barbui, Martin Griesshammer
Journal: Blood
Blood (2008) 112 (11): 2806.
https://doi.org/10.1182/blood.V112.11.2806.2806
Published: 2008
Journal Articles

Treatment with Pegylated Interferon α (PegIntron) for High-Risk Essential Thrombocythemia: Results of a Phase II Study.

Christian Langer, MD, Eva Lengfelder, MD, Jurgen Thiele, MD, Hans M. Kvasnika, MD, Heike Pahl, PhD, Axel Matzdorff, MD, Barbara Stade, Stefanie Schauer, Heinz Gisslinger, MD, Hartmut Dohner, MD, Martin Griesshammer, MD
Journal: Blood
Blood (2004) 104 (11): 1522.
https://doi.org/10.1182/blood.V104.11.1522.1522
Published: 2004